{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T22:46:41Z","timestamp":1783810001639,"version":"3.55.0"},"reference-count":61,"publisher":"Oxford University Press (OUP)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>In many jurisdictions, public safety and public health entities are working together to enhance the timeliness and accuracy of the analytical characterization and toxicology testing of novel synthetic opioids. The improved sharing and early detection of these analytical data are intended to inform surveillance, interdiction efforts, patient intervention and treatment, all of which are critical to curbing the opioid epidemic. Forensic practitioners working to identify novel synthetic opioids struggle to provide timely results when encountering new or unknown substances, such as the fentanyl analogs. These compounds, which mimic heroin in pharmacologic effect but can be far more potent, are inconsistently present in chemical identification libraries, and are currently largely unavailable as reference materials for analytical comparison. Additionally, federal, state and local governments as well as nongovernmental organizations require potency, toxicity and potential-for-abuse data to evaluate the potential health risks of emerging drug threats. Subsequent scheduling efforts and criminal prosecutions also require these thorough drug characterization studies. Pilot programs have demonstrated that early communication of real-time drug toxicity and analytical data significantly impacts the successful response to emerging opioids. High-quality, real-time, national-level data on chemical composition, toxicological test data, drug toxicity and overdoses, and analysis of seized materials by law enforcement are needed to track drug trends. However, the USA still lacks a national system to coordinate and communicate toxicology, medical and medical examiner and coroner data with the broader medical and law enforcement communities. Opportunities to address these gaps as well as recent advancements collected through interagency efforts and technical workshops in the toxicology and analytical chemistry communities are presented here. Opportunities for partnership, increased communication and expanding best practices to move toward an integrated, holistic analytical response are also explored.<\/jats:p>","DOI":"10.1093\/jat\/bky049","type":"journal-article","created":{"date-parts":[[2018,7,14]],"date-time":"2018-07-14T10:57:17Z","timestamp":1531565837000},"page":"1-9","source":"Crossref","is-referenced-by-count":57,"title":["The Opioid Epidemic: Moving Toward an Integrated, Holistic Analytical Response"],"prefix":"10.1093","volume":"43","author":[{"given":"Jayne B","family":"Morrow","sequence":"first","affiliation":[{"name":"Material Measurement Laboratory, National Institute of Standards and Technology, 100 Bureau Drive, Gaithersburg, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeri D","family":"Ropero-Miller","sequence":"additional","affiliation":[{"name":"RTI International, Research Triangle Park, NC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan L","family":"Catlin","sequence":"additional","affiliation":[{"name":"National Heroin Coordination Group, Office of National Drug Control Policy, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnes D","family":"Winokur","sequence":"additional","affiliation":[{"name":"Office of Forensic Sciences for the Drug Enforcement Administration\u2019s (DEA) Southeast Laboratory, Miami, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy B","family":"Cadwallader","sequence":"additional","affiliation":[{"name":"Council on Science and Public Health, American Medical Association, Chicago, IL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica L","family":"Staymates","sequence":"additional","affiliation":[{"name":"Material Measurement Laboratory, National Institute of Standards and Technology, 100 Bureau Drive, Gaithersburg, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannan R","family":"Williams","sequence":"additional","affiliation":[{"name":"Office of Special Programs, National Institute of Standards and Technology, 100 Bureau Drive, Gaithersburg, MD, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan G","family":"McGrath","sequence":"additional","affiliation":[{"name":"DOJ National Institute of Justice, Office of Investigative and Forensic Sciences, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry K","family":"Logan","sequence":"additional","affiliation":[{"name":"NMS Labs, Willow Grove, PA, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael M","family":"McCormick","sequence":"additional","affiliation":[{"name":"US Customs and Border Protection, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt B","family":"Nolte","sequence":"additional","affiliation":[{"name":"Pathology and Radiology, New Mexico Office of the Medical Investigator, Albuquerque, NM, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas P","family":"Gilson","sequence":"additional","affiliation":[{"name":"Cuyahoga County Regional Forensic Sciences Laboratory, Cleveland, OH, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M J","family":"Menendez","sequence":"additional","affiliation":[{"name":"Organized Crime Drug Enforcement Task Forces, Department of Justice, Washington, DC, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce A","family":"Goldberger","sequence":"additional","affiliation":[{"name":"University of Florida, Gainesville, FL, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,8,27]]},"reference":[{"key":"2019110703360458100_bky049C1","author":"Hedegaard","year":"2017"},{"key":"2019110703360458100_bky049C2","author":"National Center for Health Statistics","year":"2018"},{"key":"2019110703360458100_bky049C3","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.15585\/mmwr.mm6643e1","article-title":"Deaths involving fentanyl, fentanyl analogs, and u-47700\u201410 states, July\u2013December 2016","volume":"66","author":"O\u2019Donnell","year":"2017","journal-title":"Morbidity and Mortality Weekly Report (MMWR)"},{"key":"2019110703360458100_bky049C4","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s13181-013-0323-x","article-title":"Complete republication: national association of medical examiners position paper: recommendations for the investigation, diagnosis, and certification of deaths related to opioid drugs","volume":"10","author":"Gregory","year":"2014","journal-title":"Journal of Medical Toxicology"},{"key":"2019110703360458100_bky049C5","author":"National Governors Association"},{"key":"2019110703360458100_bky049C6","first-page":"2","volume-title":"Drug threat is \u2018unprecedented\u2019 according to forensic experts","author":"ASCLD Board of Directors","year":"2017"},{"key":"2019110703360458100_bky049C7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/jat\/bkx031","article-title":"Reports of adverse events associated with use of novel psychoactive substances, 2013\u20132016: a review","volume":"41","author":"Logan","year":"2017","journal-title":"Journal of Analytical Toxicology"},{"key":"2019110703360458100_bky049C8","author":"ASCLD","year":"2018"},{"key":"2019110703360458100_bky049C9","volume-title":"2013 survey of crime laboratory drug chemistry sections","author":"U.S. Drug Enforcement Administration, Office of Diversion Control","year":"2014"},{"key":"2019110703360458100_bky049C10","author":"Drug Enforcement Administration","year":"2018"},{"key":"2019110703360458100_bky049C11","first-page":"287","article-title":"Blood concentrations of fentanyl and its analogs in overdose victims","volume":"26","author":"Henderson","year":"1983","journal-title":"Proceedings of the Western Pharmacological Society"},{"key":"2019110703360458100_bky049C12","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1520\/JFS11976J","article-title":"Designer drugs: past history and future prospects","volume":"33","author":"Henderson","year":"1988","journal-title":"Journal of Forensic Science"},{"key":"2019110703360458100_bky049C13","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1520\/JFS13045J","article-title":"Fentanyl-related deaths: demographics, circumstances, and toxicology of 112 cases","volume":"36","author":"Henderson","year":"1991","journal-title":"Journal of Forensic Science"},{"key":"2019110703360458100_bky049C14","first-page":"793","article-title":"Nonpharmaceutical fentanyl-related deaths\u2014multiple states, April 2005-March 2007","volume":"57","author":"Centers for Disease Control and Prevention","year":"2008","journal-title":"Morbidity and Mortality Weekly Report (MMWR)"},{"key":"2019110703360458100_bky049C15","author":"National Drug Intelligence Center, U.S. Deparatment of Justice","year":"2006"},{"key":"2019110703360458100_bky049C16","author":"U.S. Department of Justice, Drug Enforcement Administration"},{"key":"2019110703360458100_bky049C17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neuropharm.2017.10.016","article-title":"Fentanyl, fentanyl analogs and novel synthetic opioids: a comprehensive review","volume":"134","author":"Armenian","year":"2018","journal-title":"Neuropharmacology"},{"key":"2019110703360458100_bky049C18","author":"U.S. Department of Homeland Security, Customs and Borders Protection, Laboratories and Scientific Services"},{"key":"2019110703360458100_bky049C19","author":"Federal Register","year":"2018"},{"key":"2019110703360458100_bky049C20","doi-asserted-by":"crossref","first-page":"385","DOI":"10.4155\/fmc.13.215","article-title":"Fentanyl-related compounds and derivatives: current status and future prospects for pharmaceutical applications","volume":"6","author":"Vardanyan","year":"2014","journal-title":"Future Medicinal Chemistry"},{"key":"2019110703360458100_bky049C21","author":"U.S. Department of Justice, Drug Enforcement Administration","year":"2017"},{"key":"2019110703360458100_bky049C22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/FTD.0000000000000465","article-title":"Acute intoxications and fatalities from illicit fentanyl and analogues: an update","volume":"40","author":"Pichini","year":"2018","journal-title":"Therapeutic Drug Monitoring"},{"key":"2019110703360458100_bky049C23","first-page":"1","article-title":"Drugs most frequently involved in drug overdose deaths: United States, 2010\u20132014","volume":"65","author":"Warner","year":"2016","journal-title":"National Vital Statistics Reports"},{"key":"2019110703360458100_bky049C24","author":"Centers for Disease Control and Prevention","year":"2016"},{"key":"2019110703360458100_bky049C25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.15585\/mm6604a4","article-title":"Multiple fentanyl overdoses\u2014New Haven, Connecticut, June 23, 2016","volume":"66","author":"Tomassoni","year":"2017","journal-title":"Morbidity and Mortality Weekly Report (MMWR)"},{"key":"2019110703360458100_bky049C26","doi-asserted-by":"crossref","first-page":"420","DOI":"10.15585\/mmwr.mm6516e1","article-title":"Counterfeit norco poisoning outbreak\u2014San Francisco Bay Area, California, March 25\u2212April 5, 2016","volume":"65","author":"Vo","year":"2016","journal-title":"Morbidity and Mortality Weekly Report (MMWR)"},{"key":"2019110703360458100_bky049C27","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.15585\/mmwr.mm6641a6","article-title":"Notes from the field: counterfeit percocet-related overdose cluster\u2014Georgia, June 2017","volume":"55","author":"Edison","year":"2017","journal-title":"Morbidity and Mortality Weekly Report (MMWR)"},{"key":"2019110703360458100_bky049C28","author":"Heller","year":"2014"},{"key":"2019110703360458100_bky049C29","author":"New Jersey Office of the Regional Operations & Intelligence Center (ROIC)","year":"2016"},{"key":"2019110703360458100_bky049C30","author":"OverdoseFreePA (Producer)","year":"2018"},{"key":"2019110703360458100_bky049C31","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s13181-015-0477-9","article-title":"Acetyl fentanyl, a novel fentanyl analog, causes 14 overdose deaths in Rhode Island, March\u2013May 2013","volume":"11","author":"Lozier","year":"2015","journal-title":"Journal of Medical Toxicology"},{"key":"2019110703360458100_bky049C32","author":"Mettler","year":"2016"},{"key":"2019110703360458100_bky049C33","author":"Spencer","year":"2016"},{"key":"2019110703360458100_bky049C34","volume-title":"Fentanyl: a briefing guide for first responders","author":"Drug Enforcement Administration","year":"2017"},{"key":"2019110703360458100_bky049C35","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.forc.2017.04.001","article-title":"Rapid detection of fentanyl, fentanyl analogues, and opioids for on-site or laboratory based drug seizure screening using thermal desorption DART-MS and ion mobility spectrometry","volume":"4","author":"Sisco","year":"2017","journal-title":"Forensic Chemistry"},{"key":"2019110703360458100_bky049C36","author":"U.S. Customs and Border Protection","year":"2016"},{"key":"2019110703360458100_bky049C37","author":"Scientific Working Group for the Analysis of Seized Drugs (SWGDRUG)","year":"2018"},{"key":"2019110703360458100_bky049C38","author":"National Institute of Standards and Technology (NIST)","year":"2018"},{"key":"2019110703360458100_bky049C39","volume-title":"Fentanyl safety recommendations for first responders","author":"Office of National Drug Control Policy (ONDCP)","year":"2017"},{"key":"2019110703360458100_bky049C40","doi-asserted-by":"crossref","first-page":"13261","DOI":"10.1021\/acs.analchem.7b03320","article-title":"Combining fragment-ion and neutral-loss matching during mass spectral library searching: a new general purpose algorithm applicable to illicit drug identification","volume":"89","author":"Moorthy","year":"2017","journal-title":"Analytical Chemistry"},{"key":"2019110703360458100_bky049C41","author":"Scientific Working Group for the Analysis of Seized Drugs (SWGDRUG)","year":"2018"},{"key":"2019110703360458100_bky049C42","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.forc.2018.05.003","article-title":"NPS Data Hub: a web-based community driven analytical data repository for new psychoactive substances","volume":"9","author":"Urbas","year":"2018","journal-title":"Forensic Chemistry"},{"key":"2019110703360458100_bky049C43","author":"ACEP","year":"2015"},{"key":"2019110703360458100_bky049C44","author":"AMA","year":"2016"},{"key":"2019110703360458100_bky049C45","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.drugpo.2017.05.051","article-title":"Heroin and fentanyl overdoses in Kentucky: epidemiology and surveillance","volume":"46","author":"Slavova","year":"2017","journal-title":"International Journal of Drug Policy"},{"key":"2019110703360458100_bky049C46","doi-asserted-by":"crossref","first-page":"65s","DOI":"10.1177\/0033354917718074","article-title":"Developing syndromic surveillance to monitor and respond to adverse health events related to psychoactive substance use: methods and applications","volume":"132","author":"Nolan","year":"2017","journal-title":"Public Health Reports"},{"key":"2019110703360458100_bky049C47","doi-asserted-by":"crossref","first-page":"279","DOI":"10.15585\/mmwr.mm6709e1","article-title":"Vital signs: trends in emergency department visits for suspected opioid overdoses - United States, July 2016\u2013September 2017","volume":"67","author":"Vivolo-Kantor","year":"2018","journal-title":"Morbidity and Mortality Weekly Report (MMWR)"},{"key":"2019110703360458100_bky049C48","doi-asserted-by":"crossref","first-page":"231","DOI":"10.23907\/2013.029","article-title":"State variation in certifying manner of death and drugs involved in drug intoxication deaths","volume":"3","author":"Warner","year":"2013","journal-title":"Academy of Forensic Pathology"},{"key":"2019110703360458100_bky049C49","doi-asserted-by":"crossref","first-page":"319","DOI":"10.3109\/15563650.2016.1139714","article-title":"Non-targeted screening for novel psychoactive substances among agitated emergency department patients","volume":"54","author":"Lung","year":"2016","journal-title":"Clinical Toxicology (Philadelphia, PA)"},{"key":"2019110703360458100_bky049C50","doi-asserted-by":"crossref","first-page":"733","DOI":"10.3109\/15563650.2012.713108","article-title":"Role of liquid chromatography-high-resolution mass spectrometry (LC-HR\/MS) in clinical toxicology","volume":"50","author":"Wu","year":"2012","journal-title":"Clinical Toxicology (Philadelphia, PA)"},{"key":"2019110703360458100_bky049C51","author":"Forensic Technnology Center of Excellence","year":"2016"},{"key":"2019110703360458100_bky049C52","author":"Centers for Disease Control and Prevention","year":"2017"},{"key":"2019110703360458100_bky049C53","author":"National Institute of Justice (NIJ)","year":"2018"},{"key":"2019110703360458100_bky049C54","author":"Grants.gov","year":"2018"},{"key":"2019110703360458100_bky049C55","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/10937404.2010.483176","article-title":"Toxicity testing in the 21st century: a vision and a strategy","volume":"13","author":"Krewski","year":"2010","journal-title":"Journal of Toxicology and Environmental Health. Part B, Critical Reviews"},{"key":"2019110703360458100_bky049C56","author":"High Intensity Drug Trafficking Areas (HIDTA)","year":"2018"},{"key":"2019110703360458100_bky049C57","author":"Mass.gov","year":"2018"},{"key":"2019110703360458100_bky049C58","author":"Mass.gov","year":"2018"},{"key":"2019110703360458100_bky049C59","first-page":"5","article-title":"Overview of syndromic surveillance: what is syndromic surveillance?","volume":"53","author":"Henning","year":"2004","journal-title":"Morbidity and Mortality Weekly Report (MMWR)"},{"key":"2019110703360458100_bky049C60","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.humpath.2007.02.003","article-title":"\u201cMed-X\u201d: a medical examiner surveillance model for bioterrorism and infectious disease mortality","volume":"38","author":"Nolte","year":"2007","journal-title":"Human Pathology"},{"key":"2019110703360458100_bky049C61","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.annemergmed.2014.07.017","article-title":"The potential threat of acetyl fentanyl: legal issues, contaminated heroin, and acetyl fentanyl \u201cdisguised\u201d as other opioids","volume":"64","author":"Stogner","year":"2014","journal-title":"Annals of Emergency Medicine"}],"container-title":["Journal of Analytical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jat\/article-pdf\/43\/1\/1\/30439682\/bky049.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jat\/article-pdf\/43\/1\/1\/30439682\/bky049.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,27]],"date-time":"2022-08-27T16:10:57Z","timestamp":1661616657000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jat\/article\/43\/1\/1\/5079801"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,27]]},"references-count":61,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,8,27]]},"published-print":{"date-parts":[[2019,1,1]]}},"URL":"https:\/\/doi.org\/10.1093\/jat\/bky049","relation":{},"ISSN":["0146-4760","1945-2403"],"issn-type":[{"value":"0146-4760","type":"print"},{"value":"1945-2403","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,1]]},"published":{"date-parts":[[2018,8,27]]}}}